Skip to main content

How Will German Legalization Affect Europe’s Emerging Cannabis Industry?

As a long-time cannabis activist in the United States, I have personally witnessed the ‘cannabis political butterfly effect.’ Cannabis activists worked at the state level to legalize medical cannabis for many years with no victories in the United States, although it wasn’t for lack of effort.

That all changed in 1996 with the passage of medical cannabis legalization in California. That one victory would quickly prove to be the first domino that would knock over several others in the years that followed, with state after state passing measures via citizen initiative or legislative action.

The same thing happened with adult-use legalization. The first states to legalize in the U.S. were Colorado and Washington in 2012, and roughly a decade later the list has grown exponentially to 22 states, two territories, and Washington D.C. Both policy shift patterns demonstrate the butterfly effect.

This is not to say that every reform victory sets off a public policy chain reaction. Obviously, Uruguay legalized cannabis for adult use and it was not until a handful of years later that Canada did the same, and then a few years after that before Malta passed its own legalization measure. Those examples highlight that not all prohibition dominos are created equal.

One international legalization domino is looming over all the rest right now – Germany. Germany is in the middle of a historic push to pass a national legalization measure, and we now know many of the policy facets that will be involved, although it’s still unclear what many of the regulatory requirements will be.

What is clear is that Germany is likely to spark a series of similar reform measures being introduced and passed in other countries, particularly in Europe. It is completely logical to assume that there will be a policy butterfly effect once Germany legalizes, unlike what has happened so far in Canada, Uruguay, and Malta.

Germany shares more borders (9) with other countries than any other nation in Europe. It is very unlikely that successful legalization in Germany will fail to move the needle in the region. Leaders in the Czech Republic have already publicly indicated that they will follow Germany’s lead, and presumably, several other countries are just waiting for Germany’s process to get further along before they do the same.

Germany is home to the world’s fourth-largest economy and holds tremendous political influence at the continental and global levels. Legalization in Germany is going to encourage countries throughout the world to get on the ride side of history and work to end cannabis prohibition at a level never previously witnessed since the dawn of prohibition.

This is all stellar news for the emerging legal international cannabis industry, as every reform victory yields new opportunities for entrepreneurs, investors, industry service providers, etc. Cannabis reform is on the move around the world, particularly in Europe, and that directly benefits overall industry pursuits.

With that being said, there are still many questions to be answered, not the least of which are how fast can people expect things to start moving, and where should they focus their attention. Some nations are going to move faster than others, and some markets are going to be worth holding out for compared to other markets that may have a lower barrier to entry but less profit potential.

Figuring that all out is not an easy task, and that is why we are encouraging people to come to learn straight from one of the best in the business at the upcoming International Cannabis Business Conference in Berlin on July 29-30th. Renowned international cannabis expert Peter Homberg will provide a keynote address dedicated to the topic of how legalization in Germany will affect the international cannabis industry. Peter Homberg is a partner at Dentons, the world’s largest law firm, and possesses a wealth of knowledge of cannabis policy and industry trends.

Over 5,000 cannabis leaders from over 80 countries will be represented at the International Cannabis Business Conference in Berlin and that includes representatives from every sector of the industry as well as leading international cannabis policymakers and industry service providers. Attend the International Cannabis Business Conference in Berlin to network with investors, entrepreneurs, industry regulators, and international policymakers and take your industry pursuits to the next level.

Secure your tickets now before the event is sold out!

Spain’s Minister Of Health Says Medical Cannabis Regulations Are On The Way

Spain has long served as a unique home for cannabis public policy. Technically, medical cannabis is prohibited in many instances in Spain, with the nation’s legal medical cannabis industry largely built around research and exports.

Domestic medical cannabis patients are almost always left on the outside looking in and have to resort to unregulated sources for their medicine. Fortunately for patients, medical cannabis is fairly easy to acquire in Spain from private cannabis clubs, however, the situation highlights that Spain’s cannabis model is in desperate need of improvement.

When patients and providers have to operate in an unregulated environment, there is a considerable amount of uncertainty involved and that makes it difficult to keep things going at times. Unregulated industries are ripe for selective enforcement towards providers, and patients may end up buying untested products that are not as ‘clean’ as they could be.

Advocates have pushed for reform in Spain for many years, and yet, success has remained elusive. Medical cannabis patients and industry members were hopeful that 2022 would be the year for a regulation bill to get to the finish line just to see their hopes dashed. Fortunately, the nation’s Minister of Health is signaling that movement is on the way. Per El Planteo:

The Minister of Health of Spain, José Manuel Miñones , announced that before the end of May he will present a report that will allow the regulation of the use of medicinal cannabis in the National Health System (SNS) . The news came after some parliamentarians have claimed the delay in the analysis of the Spanish Agency for Medicines and Health Products (Aemps), whose term ended in 2022.

Miñones also apologized for the delay in his first appearance before the Health Commission of the Lower House. Congress had ruled in favor of regulating medical cannabis in June 2022, and the subcommittee in charge had given Aemps a period of six months to issue recommendations.

What is being proposed is instead of regulating the nation’s private cannabis clubs, patients will be able to legally acquire medical cannabis and products derived from medical cannabis via one of Spain’s licensed pharmacies.

In some countries, such as the United States, pharmacies are not used to dispense medical cannabis outside of a handful of pharmaceutical-grade products. In other countries, such as Germany, pharmacies are used to serve as the backbone of safe access for suffering patients. Whether something meaningful comes out of Spain or not is something that we will all have to wait and see.

Is Legalization In Canada Linked To Upticks In Traffic Crashes?

Historically, in every single jurisdiction on earth where legalization was pursued and achieved, without exception, there were cannabis opponents spreading anti-cannabis myths and half-truths to try to deter voters or lawmakers from supporting reform.

One of the most popular areas of focus for cannabis opponents was, and presumably always will be, impaired driving. The talking point can come about in a variety of forms, however, the main premise of the talking point regardless of how it manifests itself is this – that if cannabis laws are reformed there will be terror on the roadways in the form of increased vehicle crashes.

Unfortunately for cannabis opponents, and fortunately for rational-thinking people worldwide, the data does not support opponents’ claims. A recent study out of Canada highlights what really happens (or doesn’t happen) after a nation legalizes cannabis for adult use. Below is more information about it via a news release from NORML:

Sherbrooke, Canada: Neither the passage of adult use marijuana legalization nor the growth of retail cannabis sales is associated with any increase in motor vehicle accidents, according to data published in the journal Drug and Alcohol Review.

Canadian investigators assessed trends in traffic crashes in Toronto in the years prior to and immediately following the adoption of adult-use legalization.

They reported: “[N]either the CCA [Canadian Cannabis Act] nor the NCS [number of cannabis stores per capita] is associated with concomitant changes in (traffic safety) outcomes. … During the first year of the CRUL’s [cannabis recreational use laws] implementation in Toronto, no significant changes in crashes, number of road victims and KSI [all road users killed or severely injured] were observed.”

The findings are consistent with those of other Canadian studies. One study, published last year in the journal Drug and Alcohol Dependence, “ found no evidence that the implementation of the Cannabis Act was associated with significant changes in post-legalization patterns of all drivers’ traffic-injury ED [emergency department] visits or, more specifically, youth-driver traffic-injury ED presentations.”

Another study, published earlier this year, similarly concluded, “Overall, there is no clear evidence that RCL [recreational cannabis laws] had any effect on rates of ED visits and hospitalizations for either motor vehicle or pedestrian/cyclist injury across Canada.”

Full text of the study, “Did the cannabis recreational use law affect traffic crash outcomes in Toronto? Building evidence for the adequate number of authorized cannabis stores’ thresholds,” appears in the journal Drug and Alcohol ReviewAdditional information is available from the NORML Fact Sheet, ‘Marijuana and Psychomotor Performance.

Switzerland Cannabis Pilot Programs Set To Expand

Switzerland is home to a cannabis commerce public policy experiment that is based on a concept which is seemingly growing in popularity in policy and regulatory circles. The concept, limited regional cannabis commerce pilot projects, is already in operation in Basel, Switzerland where 374 people between the ages of 18 and 76 can make legal adult-use cannabis purchases.

Additional pilot programs were approved for Zurich, Geneva, Lausanne, and Bern, with Bern’s pilot program set to launch this fall. The pilot program in Bern ‘plans to recruit 1,091 participants, including approximately 600 in the federal city’ according to domestic reporting.

Zurich is Switzerland’s largest city with a population of roughly 400,000 people, although the overall metro area pushes that number considerably higher. Zurich’s pilot program is expected to launch at the end of the summer and will involve 3,000 participants when fully operational. Participants will be able to make legal cannabis purchases from an expected 21 regulated outlets in Zurich.

Switzerland is not the only nation pursuing plans for regional pilot programs. Officials in Denmark are pursuing their own plans, and Germany is likely to eventually become the largest embracer of such public policy efforts. German lawmakers are working right now to hammer out details that will serve as the foundation for the nation’s pilot programs.

Officials in Frankfurt and Offenbach have already declared their intentions to launch pilot programs, and they are surely not alone. Germany will not be the first place where pilot programs are launched, however, the nation that serves as home to the largest economy in Europe will likely prove to be the place where pilot programs become the most common, and on a much larger scale than what will be found in Switzerland.

The expansion of pilot programs in Switzerland is worthy of celebration to be sure, although the scope of the nation’s pilot programs needs to be kept in proper context. They are very limited in size and are not coupled with noncommercial cannabis clubs like what is being pursued in Germany and proposed in the Czech Republic.

What Switzerland really needs, and this is true for every country on earth, is a robust cannabis policy that ensures safe access to all forms of medical cannabis for suffering patients, and incorporates regulated adult-use commerce for all cannabis products, regardless of THC content, to help boost public health outcomes.

Network With International Cannabis Investors At The Berlin Global Investment Forum

Proper timing is a vital ingredient to success in every industry, and particularly so in the emerging international cannabis industry.

The legal cannabis space is still very young, especially at the global level, and many investors, entrepreneurs, industry service providers, policymakers, and regulators are networking extensively right now to figure out who to collaborate with.

Being at the right place at the right time can literally mean the difference between crushing it in the emerging industry in the coming years or fading away.

The upcoming International Cannabis Business Conference Global Investment Forum, taking place on June 27th in Berlin, is the best time and place to effectively network with true global cannabis leaders, including top industry investors.

It is extremely rare that this many true global cannabis experts and leaders get together in one place, and even rarer for an event to host the caliber of individuals and entities that will be speaking and/or attending this specific forum.

Below is a list of speakers that will be participating in the Global Investment Forum in Berlin:

  • David Traylor – Senior Managing Director, Golden Eagle Partners
  • Peter Homberg – Partner, Dentons Head of European Cannabis Group
  • Ngaio Bealum – Conference Master of Ceremonies
  • Jamie Pearson – International Consultant, New Holland Group
  • Todd Born – Co-Founder and CEO, The Alpen Group
  • Steve Winokur – Global Head of Cannabis Investment Banking, Canaccord Genuity Corp.
  • Carmen Doran – CEO of Helius Therapeutics, Board Member of the New Zealand Medicinal Cannabis Council
  • Constantin von der Groeben – Co-Founder and Managing Director, Demecan
  • rer. nat. Adrian Fischer – Co-Founder and Managing Director, Demecan
  • Vera Broder – CEO, MHI Cultivo Medicinal SA.
  • Joel Redelman – Founding Partner, Redfield Group, Chairman, Promethean Biopharma
  • Benedikt Sons – Co-Founder, Managing Director and CEO of Cansativa Group
  • Robert T. Hoban – Member, Co-Chair of the Cannabis Industry Group, & Member-in-Charge of the Clark Hill Denver Office
  • Nic Easley – CEO, 3C Consulting & Multiverse Capital Managing Director
  • Alex Rogers – CEO & Executive Director, International Cannabis Business Conference
  • Oliver Lamb – Co-Founder and Investment Manager, Oskare Capital
  • Hilary Black – Pionner, Founder, and Advisor
  • Alex Revich – Equity Partner at Hybrid Pharm, Cannabis Education & Medical Parternships at Loosh Brands
  • Cornelius Maurer – Co-Founder, Demecan
  • Kai-Friedrich Niermann – Founder, KFN+ Law Office
  • Lewis Koski – Chief Strategy Officer (CSO) Metrc LLC
  • Lisa Haag – Founder, MJ_Universe
  • Giovanni Venturini Del Greco – Founder and CEO, Herbolea Biotech
  • Daniel Haymann – Legal Counsel, MME Legal
  • Trenton Birch – Co-Founder & CEO, Cheeba Africa
  • Luc Richner – CEO Founder, Cannavigia
  • Marcus Moser – MB & Partner, Zurich Und Moser consulting, Guglingen

The Global Investment Forum will be held at the Hotel Adlon Kempinski Berlin on June 27th. A VIP reception will occur the night prior at the exclusive Adlon Terrace in the shadow of the iconic Brandenburg Gate.

Given the historical push to legalize cannabis in Germany right now, the setting for the Global Investment Forum VIP reception could not be better.

You can view the International Cannabis Business Conference Global Investment Forum’s full schedule at this link here. Ticket prices go up on May 17th at 11:59 PM – register now and save!

Unpacking The Recent Historic Cannabis Court Decision In Uganda

This month in Uganda has been one for the ages from a cannabis policy standpoint. Earlier in May, Uganda’s Constitutional Court in Kampala rendered a decision that reportedly nullified the nation’s entire Narcotic Drugs and Psychotropic Substances Control Act. The Court reasoned that the measure was passed “without the required quorum in Parliament.”

That decision set off a wave of celebration both within Uganda and beyond its borders, with many domestic and international cannabis observers touting the decision as the Court having ‘legalized cannabis.’ However, as with many cannabis-based court decisions handed down around the globe, the actual truth of the matter is not nearly as straightforward.

Judiciary Pushes Back On Claims Of Legalization

The Petitioners of the case in question, Wakiso Miraa Growers and Dealers Association Limited, argued that there was a ‘lack of quorum by Parliament’ during the initial process of passing the Narcotic Drugs and Psychotropic Substances Control Act. Ultimately, Uganda’s Constitutional Court agreed with that argument, however, the Court adamantly disagreed with the assertion cannabis was legalized in the East African nation.

In a press statement, the Judiciary clarified that its ruling was fairly limited in scope and that it did not intend to legalize cannabis in Uganda via its recent decision. Rather, the Court expressly indicated that its intent was to nullify the process by which ‘provisions of sections 26, 29, 47, 49, and 60 (1) (b) and (c) of the National Drug Policy and Authority Act’ was adopted, but that substances ‘previously restricted under the National Drug Policy and Authority Act remain restricted’ and that ‘Parliament still reserves the power to legislate on the same subject’ if it wants to, which it presumably will.

The decision in Uganda was historic, however, not at the magnitude that many cannabis advocates had hoped, or in some cases, claimed. The fight to end cannabis prohibition in Uganda is, unfortunately, far from over. As such, cannabis advocates inside and outside of Uganda need to keep pursuing their efforts to achieve reform. Medical cannabis production is currently legal in Uganda, as are exports, however, the nation’s industry is still very limited by many measures.

Previous Cannabis Decisions In Other Countries

A cannabis-based court decision being rendered at a nation’s highest level, no pun intended, is not unique to Uganda. In September 2018, South Africa’s Constitutional Court rendered a unanimous ruling in which it deemed private, personal cannabis cultivation and consumption to be constitutional. The case stemmed from three consumers who were facing charges and argued that cannabis prohibition as it pertains to individual freedoms “intrudes unjustifiably into their private spheres.” Deputy Chief Justice Raymond Zondo said at the time that, it will “not be a criminal offense for an adult person to use or be in possession of cannabis in private for his or her personal consumption.” The decision did not extend to anything beyond private, personal cultivation, possession, and consumption.

Roughly a month after the historic decision was issued in South Africa, a somewhat similar decision was issued in Mexico. In late 2018, Mexico’s Supreme Court determined that an outright prohibition of cannabis was unconstitutional. Part of the Court’s ruling involved tasking lawmakers in Mexico with passing a legalization measure by an initial deadline. Unfortunately, the initial deadline and all subsequent extensions have yet to be complied with, as obviously, no legalization measure has reached the finish line in Mexico all of these years later.

A third major decision occurred in Italy in late 2019, where the nation’s Supreme Court also deemed the prohibition of private, personal cannabis cultivation to be unconstitutional. The case stemmed from an individual facing charges for cultivating two plants. The decision in Italy was similar to the previous ones issued in South Africa and Mexico, in that the scope of the decision was somewhat limited, and much was left to lawmakers to figure out. And just as reform efforts have languished in Italy, the same is true in South Africa and Mexico. They are all examples of court cases being both contextually historic and yet ultimately limited in scope in the long run.

Germany’s Adult-Use Cannabis Legalization Plan Is Leaked, Again

If you have spent a considerable amount of time in politics then you know that a classic tactic to build public pressure during political negotiations is to leak details to the media. After all, it’s one thing to negotiate a measure out of public view, but often an entirely different matter when the public gets to weigh in.

International cannabis observers already got to see the tactic in action back in October 2022 when an alleged draft of German Minister Karl Lauterbach’s legalization plan was leaked to the media and it resulted in considerable public outcry against certain provisions of the plan. Later in the month when Minister Lauterbach made his historic presentation to Germany’s federal cabinet the plan had evolved for the better, and it’s a safe bet that public outcry had something to do with that.

After Minister Lauterbach’s presentation in October 2022, Minister Lauterbach started lobbying the European Union to try to gain its permission for Germany to proceed with adult-use legalization. Minister Lauterbach eventually held a press conference, joined by other members of Germany’s government, and provided details regarding negotiations with the European Union. As we all now know, some of the provisions of Minister Lauterbach’s initial plan were deemed acceptable by the EU and some were not.

Home cultivation, possession, noncommercial cannabis clubs, and eventually regional adult-use pilot programs were approved according to Minister Lauterbach, however, nationwide adult-use sales will have to wait. For now, policymakers in Germany need to craft laws, rules, and regulations for what is in scope for the first two phases of adult-use legalization. German lawmakers simply stating that noncommercial cannabis clubs are permitted is obviously not enough, and there’s a political process well underway in Germany to hammer out all of the necessary details.

In news that is not at all surprising to me, another leak has occurred in Germany and it is shedding some light as to where domestic negotiations currently stand. Much of what was leaked and reported on in Germany seems to surround noncommercial cannabis clubs, which will be strictly regulated and purely “cultivation associations.” According to domestic reporting, no cannabis can be consumed “within the clubs and within a radius of 250 meters.” Below are additional provisions included in the draft that was acquired by the German Press Agency:

  • All club properties where cannabis is cultivated and/or stored have to be tightly secured
  • Every club has to have a ‘trained addiction and prevention officer’
  • Must comply with residue limits for pesticides and fertilizers
  • Must track cannabis from seed
  • Annual reporting of crop amounts, including cannabinoid percentage (THC and CBD)
  • Club members only
  • 50 grams per month limit for over 21 years old
  • 30 grams per month limit for 18-20 years old
  • THC percentage cap for 18-20 years old (ten percent THC)
  • Neutral packaging
  • Labeled with specific harvest information

In addition to club provisions, items pertaining to individuals were also reportedly included in the leaked draft. Consumption is prohibited “within a radius of 250 meters from schools, daycare centers, playgrounds, youth facilities or sports facilities.” Also, consumption “should also not be permitted in pedestrian zones between 7 a.m. and 8 p.m.”

Other provisions that were previously known appear to be unchanged in the recently leaked draft, including limiting consumers to one club membership at a time and permitting the cultivation of up to 3 plants. Pharmacies are not allowed to cultivate or sell adult-use cannabis under the leaked plan, and medical cannabis “is to be removed from the scope of the Narcotics Act.” In fact, medical cannabis reportedly has its own separate chapter in the draft law, which will hopefully provide a boost in safe access for patients, as well as help streamline cannabis research project approvals.

Some of the previously listed provisions seem to be drawing more outcry than others, however, it’s very important to recognize that the political process is far from over and that what was leaked was merely a draft. If people in Germany are fired up about a particular provision, or multiple provisions, now is the time to contact lawmakers and urge them to push for necessary amendments to the measure.

Attend CannaPortugal On May 19th And 20th

It is a truly historic era right now for cannabis policy, industry, and research, particularly on the European continent. Adult-use legalization is receiving significant attention in Europe right now, and understandably so. However, there’s currently far more going on with the continent’s emerging legal cannabis industry than just the push to legalize adult-use sales.

Europe’s legal medical cannabis industry continues to make strides at the national level, and ‘cannabis light’ is a sector of the industry that is growing in popularity. Products focused on hemp-derived CBD and lesser-known cannabinoids continue to enter the space as well.

All the while laws are being reformed, rules and regulations are being implemented, and consumer and patient trends continue to evolve. With so much going on in Europe’s cannabis industry, it can be difficult to keep up with the best and most timely information.

The CannaPortugal International Hemp and Cannabis Expo will take place on May 19th and 20th at the Centro de Congressos de Lisboa/Junqueira and we are encouraging people that are serious about the cannabis industry to consider attending. The event will bring hundreds of investors and specialists from more than a dozen countries together in a single space, in addition to featuring exhibitors and celebrities from the cannabis research and economic sectors.

“This is an event with established credits, in Lisbon, which aims to disseminate scientific knowledge, add value and accompany the expansion of the hemp sector, in particular, and cannabis, in general, as well as to reinforce the entire production process, without forgetting the positive impact that cannabis activity has in the field of human rights, quality of life, health, sustainability of the planet and economic development.” event organizers stated in a press release.

CannaPortugal integrates several initiatives, with a view to different professional areas and audiences. In addition to the Fair component of the event, with close to a hundred companies and national and international projects, the Expo integrates a B2B (business to business) program.

Additionally, CannaPortugal will feature professional workshops, to be carried out by specialist trainers in the area of ​​cannabis medicine, including:

  • Dr. Tanja Bagar, Slovenia
  • Dr. Neuza Fernandes, Brazil
  • Dr. Rafael Traldi, Brazil
  • Hugo Monteiro, Portugal
  • Chef Luís Pimenta, Portugal

CannaPortugal will also feature debates and round tables, with renowned national and international speakers, including:

  • Luna Stower, USA
  • Marcelo De Vita Grecco, Brazil
  • Del HendriXson, USA
  • João Taborda Gama, Portugal
  • Peter Homberg, Germany
  • Marcelo Demp, Paraguay
  • Elad Kaspin, Israel-Portugal
  • Maria Lourdes Serpa, USA
  • Giocomo Bulleri, Italy
  • Maren Krings, Germany
  • Sofia Fernandes, Portugal
  • Pedro Anastácio, Portugal
  • Bozidar Radisic, Slovenia
  • Carlos Beltrão, Spain
  • Neuza Fernandes, Brazil
  • Grant M. Saxena, USA
  • André Fajardo, Brazil
  • Eric Boone, USA
  • Francisco Almeida Ferraz, Portugal
  • Mila Jansen, Holand
  • Rita Oliveira, Portugal
  • Maurício Galvão, Brazil
  • Aimée- Aimée A. Drouin, USA
  • Carla Da Silva, Canada

The Expo also includes a wide range of innovative cultural activities, including the Global Cannabis Awards to honor personalities, countries, and projects that have contributed to the advancement of the cannabis industry around the globe.

Also, the event will include the HempAction Cannabis Fashion Show by GreenFits and Neuron Bonus with the participation of Weedog (Brazil) Cannabis Holistic Therapeutic Center. There will also be the Cannabis Art Space, a Media Center for the media and influencers, the Enthronement of the Confraria Internacional Cannabis Portugal, a Car Exhibition with hemp components, a Cannabis Food and Drinks Court, as well as music by Carlota Barros, vocalist of Telefonia.

CannaPortugal will be open on May 19th and 20th from 10am to 8pm. On May 21st, CannaPortugal participants and visitors will be offered a special tour of the capital – “Lisbon Cannabis Historical Tour” – which aims to explore the relationship between Portugal and the traditional cultivation of hemp in the country.

You can find out more about CannaPortugal and purchase tickets at: https://cannaportugal.com

German Officials Circulate Draft Adult-Use Cannabis Legalization Bill

The push to legalize cannabis for adult use in Germany is far from a new thing. To some extent, activists inside and outside of Germany have fought to end prohibition in Germany since the start of prohibition. However, a major milestone in the nation’s legalization efforts came in mid-2021 when a new governing coalition was elected in Germany.

Members of the new coalition made it clear that they would be pursuing adult-use legalization, and since that time the world has waited on pins and needles waiting for any movement on the formal introduction of a measure.

In October 2022, Germany’s Health Minister Karl Lauterbach provided an update to the federal cabinet, followed by a press conference earlier this year providing yet another update. Both times Minister Lauterbach hinted at the future introduction of a measure, yet provided no specific dates.

At long last, it appears that Minister Lauterbach has finally introduced a measure, albeit a scaled-back version of what was initially touted back in 2021. According to domestic reporting, the draft measure was submitted and ‘has now been sent to the other ministries for inspection and examination.’

Draft laws are not made public at this juncture, however, if it’s what Minister Karl Lauterbach described in his press conference last month, then quite a few components of the legalization plan are already out there. What Lauterbach previously described involves what ultimately amounts to a three-pronged legalization strategy.

The first phase is legalization as it pertains to individual freedoms, including possession of up to 25 grams, cultivation of up to three plants, and the launch of noncommercial cannabis clubs. The second phase involves the launch of regional adult-use commerce pilot projects.

A third phase, which was not expressly stated as such in Minister Lauterbach’s recent press conference, involves Minister Lauterbach continuing to lobby the European Union to gain its permission for Germany to launch national sales to anyone of legal age.

While the lobbying effort is not officially recognized as a third phase by lawmakers in Germany, effectively, it serves as a third iron in the German legalization fire and will take longer to make into a reality compared to the other two.

For many months I have described Minister Lauterbach as being a political pinball and bouncing back and forth between the EU and Germany. The process is now moving forward domestically, albeit slowly, and that is an exciting thing to think about as Europe’s largest economy inches ever closer to legalization.